Identification of bupropion urinary metabolites by liquid chromatography/mass spectrometry

被引:24
作者
Petsalo, Aleksanteri
Turpeinen, Miia
Tolonen, Ari
机构
[1] Novamass Analyt Ltd, Medipolis Ctr, Oulu 90220, Finland
[2] Univ Oulu, Dept Chem, Oulu 90014, Finland
[3] Univ Oulu, Dept Pharmacol & Toxicol, Oulu 90014, Finland
关键词
D O I
10.1002/rcm.3117
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human urinary metabolism of the antidepressant bupropion was studied using liquid chromatography/time-of-flight mass spectrometry (LC/TOFMS) and liquid chromatography/tandem mass spectrometry (LC/MS/MS). A total of 20 metabolites were detected and identified. The phase I metabolism included formation of morpholinohydroxybupropion, threo- and erythrohydrobupropion, aromatic hydroxylation, butyl group hydroxylation with ketone hydrogenation and dihydroxylation. These metabolites were detected either as the free form or as glucuronide and/or sulphate conjugates. In addition also m-chlorohippuric acid was detected. Of the phase I metabolites, a dihydroxylation to the aromatic ring and to the methyl group in the middle of the substrate molecule was reported here for the first time, as well as eight of the glucuronide conjugates (to hydroxy, dihydroxy, hydroxy and hydrogenation metabolites) and three of the sulphate conjugates (to aromatic hydroxy and hydroxy and hydrogenation metabolites). Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:2547 / 2554
页数:8
相关论文
共 10 条
  • [1] Behavioral and biochemical investigations of bupropion metabolites
    Bondarev, ML
    Bondareva, TS
    Young, R
    Glennon, RA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 474 (01) : 85 - 93
  • [2] High-throughput liquid chromatography-tandem mass spectrometry determination of bupropion and its metabolites in human, mouse and rat plasma using a monolithic column
    Borges, V
    Yang, E
    Dunn, J
    Henion, J
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 804 (02): : 277 - 287
  • [3] Applying mechanisms of chemical toxicity to predict drug safety
    Guengerich, F. Peter
    MacDonald, James S.
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2007, 20 (03) : 344 - 369
  • [4] Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers
    Hsyu, PH
    Singh, A
    Giargiari, TD
    Dunn, JA
    Ascher, JA
    Johnston, JA
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (08) : 737 - 743
  • [5] HPLC assay for bupropion and its major metabolites in human plasma
    Loboz, KK
    Gross, AS
    Ray, J
    McLachlan, AJ
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 823 (02): : 115 - 121
  • [6] NIXON AL, 1995, CLIN CHEM, V41, P955
  • [7] SCHROEDER DH, 1983, J CLIN PSYCHIAT, V44, P79
  • [8] Single-dose pharmacokinetics of bupropion in adolescents: Effects of smoking status and gender
    Stewart, JJ
    Berkel, HJ
    Parish, RC
    Simar, MR
    Syed, A
    Bocchini, JA
    Wilson, JT
    Manno, JE
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (07) : 770 - 778
  • [9] THE IDENTIFICATION OF IN-VITRO METABOLITES OF BUPROPION USING ION-TRAP MASS-SPECTROMETRY
    TAYLOR, LCE
    SINGH, R
    CHANG, SY
    JOHNSON, RL
    SCHWARTZ, J
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1995, 9 (10) : 902 - 910
  • [10] PHARMACOLOGICAL SIGNIFICANCE OF THE SPECIES-DIFFERENCES IN BUPROPION METABOLISM
    WELCH, RM
    LAI, AA
    SCHROEDER, DH
    [J]. XENOBIOTICA, 1987, 17 (03) : 287 - 298